Sabby Management’s Lixte Biotechnology Warrants LIXTW Stock Holding History

Sabby Management’s Portfolio LIXTW Stock Details LIXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-140,089	Closed	-$107K	–	193
2021 Q2	$107K	Sell	140,089 -17,285	-11%	-$12.3K	0.02%	147
2021 Q1	$128K	Sell	157,374 -182,168	-54%	-$174K	0.02%	145
2020 Q4	$306K	Buy	+339,542	New	+$306K	0.06%	74

Other funds holding LIXTW

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sabby Management's LIXTW Position: Q3 2021 in Review

Sabby Management sold out of Lixte Biotechnology Warrants (LIXTW) in Q3 2021, closing a stake of 140,089 shares — an estimated $107K sold.

Sabby Management first reported a position in LIXTW in Q4 2020 and held it in 3 quarters. The position peaked at $306K in Q4 2020. 2 funds tracked by Wall St. Rank hold LIXTW as of Q3 2021.

Sabby Management reported no remaining Lixte Biotechnology Warrants position as of Q3 2021 after selling out during the quarter.
Sabby Management sold 140,089 Lixte Biotechnology Warrants shares in Q3 2021, an estimated $107K.
Sabby Management first reported a position in Lixte Biotechnology Warrants in Q4 2020 and held it in 3 quarters.
Sabby Management's Lixte Biotechnology Warrants position peaked at $306K in Q4 2020.
2 funds tracked by Wall St. Rank held Lixte Biotechnology Warrants as of Q3 2021.

Based on Sabby Management's 13F filing for Q3 2021, filed 15 Nov 2021.